PT-141 peptide for sale on Amazon: what you need to know

Last updated 2026-07-24

Why you won't find legitimate PT-141 on Amazon

PT-141 (bremelanotide) is a melanocortin receptor agonist approved by the FDA in 2019 under the brand name Vyleesi for hypoactive sexual desire disorder (HSDD) in premenopausal women ^[1]. That approval makes it a prescription drug under federal law. Amazon's policies prohibit the sale of prescription drugs on its marketplace ^[2]. Any listing claiming to sell PT-141 for human use on Amazon violates both FDA regulations and Amazon's terms. The FDA classifies bremelanotide as a peptide requiring physician oversight because its safety profile includes nausea in roughly 40% of users, transient blood pressure increases, and potential skin hyperpigmentation with chronic use ^[3]. These risks demand medical evaluation and monitoring. What you will find on Amazon are products labeled "PT-141 research chemical," "PT-141 for laboratory use," or similar disclaimers. These items are manufactured by unregulated suppliers, typically overseas, and carry no purity verification, no sterility assurance, and no batch testing ^[4]. They're sold with a legal fig leaf that says "not for human consumption," but the listings often include dosing advice, testimonials about sexual effects, and other context that makes the intended use obvious. The FDA has repeatedly warned that purchasing such compounds is both illegal under the Federal Food, Drug, and Cosmetic Act and dangerous ^[5]. The regulated version (Vyleesi) is a subcutaneous injection supplied in single-use autoinjectors containing 1.75 mg bremelanotide. It's prescribed on-demand, administered 45 minutes before anticipated sexual activity, with a maximum frequency of one dose per 24 hours and no more than eight doses per month ^[1]. That specific dosing and packaging cannot be replicated by an unregulated lab selling powder in plastic baggies.

What are those Amazon listings actually selling?

Most Amazon PT-141 listings fall into three categories: research peptides, mislabeled supplements, or dropshipped counterfeits. Research peptides are synthesized by chemical suppliers that cater to academic labs and biotech companies. These suppliers are not registered drug manufacturers. They produce peptides in bulk, often in China or India, without the sterility controls, endotoxin testing, or purity verification required for human pharmaceutical use ^[4]. The product arrives as a lyophilized powder, sometimes with bacteriostatic water, sometimes without. There's no certificate of analysis from an independent lab, no FDA inspection, and no recall mechanism if contamination is discovered. Mislabeled supplements are the second category. Some sellers list products containing amino acid blends, tribulus, maca, or other over-the-counter ingredients and label them as "PT-141" or "bremelanotide analog" in the hope that consumers won't read the fine print. These are garden-variety sexual wellness supplements with no melanocortin activity whatsoever. Dropshipped counterfeits are the third. These are listings created by resellers who never handle inventory. The order is forwarded to an overseas supplier, and the product ships directly from a warehouse in Shenzhen or Mumbai. The packaging may mimic Vyleesi, but the contents are unknown. The FDA has seized shipments of counterfeit peptide drugs at the border repeatedly and found everything from wrong active ingredients to bacterial contamination ^[5]. None of these categories undergoes FDA review. None is legal for human use. If a seller gets caught, Amazon removes the listing, the seller opens a new account, and the cycle repeats.

Is it legal to buy PT-141 without a prescription?

No. Bremelanotide is a prescription drug under 21 U.S.C. 353(b), which means it may only be dispensed by a licensed pharmacist pursuant to a valid prescription from a licensed practitioner ^[6]. Buying it from an unlicensed seller, on Amazon or elsewhere, is illegal under federal law. The seller's disclaimer that the product is "for research use only" does not create a legal safe harbor. The FDA evaluates intended use based on labeling, marketing, and the circumstances of sale ^[7]. If the product is marketed with dosing instructions, customer reviews describing human use, or any other context suggesting human consumption, the FDA considers it a misbranded drug regardless of the disclaimer. Some consumers believe that because PT-141 is a peptide, it falls outside drug regulation, similar to how protein powder is a dietary supplement. That's not how the law works. Peptides that have a pharmacological effect (bremelanotide activates melanocortin-4 receptors in the hypothalamus and produces measurable changes in sexual desire and physiological arousal ^[8]) are drugs, not food. The FDA has explicitly stated that peptides sold for bodybuilding, sexual enhancement, or anti-aging are unapproved drugs, not supplements, and purchasing them is a violation of the FD&C Act ^[5]. Customs and Border Protection (CBP) screens international mail and packages for undeclared drugs. Bremelanotide shipments from overseas suppliers are subject to seizure. If CBP intercepts your package, you'll receive a notice offering you the chance to contest the seizure or abandon the goods. Most people abandon. In rare cases, the FDA refers the buyer to the Department of Justice for prosecution, though that's typically reserved for large-scale importers or repeat offenders ^[5].

What are the risks of unregulated PT-141?

Unregulated PT-141 poses three categories of risk: contamination, incorrect dosing, and unknown identity. Contamination is the most immediate danger. Peptide synthesis produces byproducts (truncated sequences, acetylated fragments, trifluoroacetate salts) that must be removed through purification ^[4]. Research-grade suppliers often skip the final high-performance liquid chromatography (HPLC) step to save cost. The result is a product that may be 60%, 70%, or 85% pure, with the remainder being biologically active impurities. Injectable impurities can trigger immune reactions, pyrogenic responses (fever and chills from endotoxins), or hypersensitivity reactions ^[4]. Bacterial contamination is another concern. Pharmaceutical peptides are manufactured in clean rooms under strict aseptic conditions and undergo sterility testing before release. Research peptides are synthesized in standard chemistry labs and lyophilized in non-sterile environments. If you reconstitute that powder with bacteriostatic water and inject it, you're introducing unknown microbial content into your bloodstream. The FDA has documented cases of serious infections, including sepsis, linked to non-sterile peptide injections ^[5]. Incorrect dosing is the second risk. The FDA-approved dose of bremelanotide is 1.75 mg per injection, based on Phase 3 trials that tested multiple dose levels and found that higher doses increased nausea without improving efficacy ^[9]. Unregulated suppliers provide no dosage guidance beyond anecdotal forum posts. Users guess at reconstitution volumes and draw up doses based on internet advice. Overdosing increases the risk of sustained hypertension, severe nausea, and hyperpigmentation. Unknown identity is the third risk. There's no way to verify that the powder in the vial actually contains bremelanotide. It could be a different peptide (melanotan II, which has similar but distinct effects and different side effects), a completely inert substance, or a contaminated batch. Third-party testing costs several hundred dollars and requires access to a lab with HPLC and mass spectrometry. Most buyers never test.

How does legitimate PT-141 (Vyleesi) get prescribed?

Legitimate bremelanotide starts with a clinical diagnosis of hypoactive sexual desire disorder. HSDD is defined as persistent or recurrent deficiency in sexual fantasies and desire for sexual activity that causes marked distress or interpersonal difficulty, not attributable to another medical condition, medication side effect, or relationship problem ^[10]. The diagnostic process includes a detailed sexual health history, review of medications (SSRIs, beta-blockers, and hormonal contraceptives all reduce libido), screening for depression and anxiety (both suppress desire), and sometimes hormone testing to rule out low estrogen, thyroid dysfunction, or hyperprolactinemia ^[10]. If HSDD is confirmed and the patient is premenopausal, bremelanotide is one of two FDA-approved pharmacologic options. The other is flibanserin (Addyi), a daily oral medication with a different mechanism (serotonin receptor modulation) ^[10]. Vyleesi is prescribed on-demand. The patient self-administers a 1.75 mg subcutaneous injection into the abdomen or thigh 45 minutes before anticipated sexual activity ^[1]. The drug reaches peak plasma concentration in about one hour and has a half-life of approximately 2.7 hours ^[1]. Effects on desire and arousal are noticeable within 1 to 2 hours and last 6 to 8 hours. The most common side effects are nausea (40% of users), flushing (20%), injection site reactions (13%), and headache (11%) ^[3]. Nausea typically peaks 2 hours after injection and resolves within 4 hours. Taking the injection on an empty stomach worsens nausea, so most prescribers advise patients to eat lightly beforehand. About 1.3% of users in clinical trials stopped the drug due to nausea ^[3]. Bremelanotide causes a transient increase in blood pressure (average 3 to 4 mmHg systolic) and a transient decrease in heart rate (average 5 to 10 bpm) ^[3]. These changes peak 4 hours after injection and return to baseline by 12 hours. Patients with uncontrolled hypertension or cardiovascular disease are not candidates for the drug ^[1]. The prescribing process also includes counseling about darkening of the skin and gums. Melanocortin receptor agonists stimulate melanin production, and prolonged use can cause permanent hyperpigmentation ^[1]. The risk is low with on-demand use (maximum eight doses per month), but patients with naturally darker skin or a history of melasma should be aware of it. Prescriptions are filled by retail pharmacies or specialty pharmacies. Vyleesi is not stocked by all chains because demand is low relative to other sexual health drugs. Cost is $800 to $1,000 per month without insurance ^[1]. Some insurers cover it, many do not. The manufacturer offers a savings card that reduces copays to $0 for the first month and $99 per month thereafter for commercially insured patients. Provider-supervised compounding is the second legitimate route. Bremelanotide is not on the FDA's 503A or 503B bulk drug substance lists ^[11], which means compounding pharmacies may not compound it unless the patient has a documented allergy or intolerance to Vyleesi's inactive ingredients (a rare scenario) or the drug is in shortage (which it currently is not). Some online telemedicine platforms claim to offer compounded bremelanotide, but unless they can document an FDA-recognized exception, that compounding is illegal ^[11]. If you're exploring this route, verify that the pharmacy is registered with the state board and ask for written documentation of the legal basis for compounding. For sourcing guidance that includes vetted provider options, see best place to buy PT-141.

How does PT-141 actually work in the body?

Bremelanotide is a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH), a naturally occurring peptide that binds to melanocortin receptors throughout the body ^[8]. There are five melanocortin receptor subtypes (MC1R through MC5R). Bremelanotide has activity at MC3R and MC4R, both of which are expressed in the central nervous system ^[8]. MC4R is the key target for sexual desire. These receptors are densely concentrated in the hypothalamus, particularly the paraventricular nucleus, which integrates sexual arousal signals ^[8]. Activation of MC4R in this region increases dopamine release in the mesolimbic pathway, the brain's reward circuit. That dopamine surge enhances motivation and desire ^[8]. Bremelanotide also activates MC3R, which is involved in energy homeostasis and inflammatory modulation. This receptor's role in sexual function is less clear, but preclinical studies suggest it contributes to the drug's effects on physiological arousal (increased genital blood flow, vaginal lubrication) ^[8]. The drug's mechanism is entirely central. Unlike sildenafil (Viagra) or tadalafil (Cialis), which act peripherally by increasing blood flow to genital tissues, bremelanotide works in the brain to increase desire before physical arousal ^[8]. That distinction is important because women with HSDD often report no difficulty with physical arousal or orgasm once sexual activity begins. The problem is lack of interest in initiating activity. A peripheral vasodilator doesn't address that. The Phase 3 trials that led to Vyleesi's approval enrolled 1,247 premenopausal women with HSDD and randomized them to bremelanotide 1.75 mg or placebo, administered on-demand for 24 weeks ^[9]. The co-primary endpoints were change in sexual desire (measured by the Female Sexual Function Index desire domain) and change in distress related to low desire (measured by the Female Sexual Distress Scale-Desire/Arousal/Orgasm). Bremelanotide significantly improved both endpoints compared to placebo ^[9]. The effect size was modest. Women on bremelanotide reported an average increase of 0.3 points on the 1.2-to-6.0 FSFI desire scale, compared to 0.2 points on placebo ^[9]. That's a real improvement, but it's not transformative. About 25% of bremelanotide users reported a clinically meaningful improvement (defined as at least 1.2 points), compared to 17% of placebo users ^[9]. The number needed to treat is roughly 12 to produce one responder. Some critics argue that the effect is too small to justify the drug's side effect profile and cost ^[12]. Others point out that HSDD is a complex biopsychosocial problem and pharmacotherapy is only one component of treatment. Cognitive-behavioral therapy, relationship counseling, and mindfulness-based interventions all have evidence in HSDD and should be considered alongside or instead of medication ^[10]. For a deeper look at the trial data and how bremelanotide stacks up, see PT-141 animal studies vs human evidence.

What about PT-141 for men?

Bremelanotide was initially developed for erectile dysfunction in men. Early trials showed that it produced erections in men with mild to moderate ED, but the effect was inconsistent and the side effect profile (nausea, flushing, prolonged erections in a small subset) was worse than PDE5 inhibitors like sildenafil ^[13]. The developer shifted focus to female HSDD, where the mechanism (central desire rather than peripheral erection) was a better fit. The FDA has not approved bremelanotide for any use in men. It is occasionally prescribed off-label by urologists or men's health clinics for situational ED or low libido, but that's outside the approved indication and insurance doesn't cover it ^[13]. Compounding pharmacies sometimes provide bremelanotide for men, but the legal basis is questionable because the drug is not on the bulk substance lists ^[11]. Anecdotal reports from men who use bremelanotide (mostly sourced from unregulated suppliers) describe increased spontaneous erections, enhanced libido, and more intense orgasms. The mechanism is presumably the same: MC4R activation in the hypothalamus increases dopamine tone. But there's no large-scale safety data in men, and the nausea that plagues 40% of female users also hits men. Some men report that the nausea is severe enough that they stop after one or two doses ^[13]. Men exploring bremelanotide should be aware that PDE5 inhibitors (sildenafil, tadalafil, vardenafil) have decades of safety data, FDA approval for erectile dysfunction, and a side effect profile that's generally milder (headache, flushing, nasal congestion, but not the sustained nausea bremelanotide causes) ^[13]. If the problem is desire rather than erection, testosterone replacement (for men with low testosterone) or bupropion (for SSRI-induced sexual dysfunction) are better-studied options ^[13]. For more on sourcing considerations specific to men, see PT-141 peptide for men near me.

How much does legitimate PT-141 cost?

Vyleesi's list price is approximately $950 for a carton of four 1.75 mg autoinjectors ^[1]. That's four doses, enough for one month at the maximum recommended frequency (eight doses per month would cost about $1,900). Most patients use it less frequently, perhaps once or twice per week, which brings the monthly cost down to $450 to $950. Insurance coverage is inconsistent. Some plans categorize Vyleesi as a lifestyle drug and exclude it entirely. Others require prior authorization, which involves documenting that the patient has tried and failed non-pharmacologic interventions and that HSDD is causing significant distress ^[1]. Approval rates for prior auth are low, anecdotally in the 30% range. The manufacturer, Palatin Technologies (licensed to AMAG Pharmaceuticals for commercialization), offers a savings program. Commercially insured patients with a valid prescription can pay $0 for the first month and $99 per month thereafter ^[1]. The program excludes patients on Medicare, Medicaid, or other government insurance. For uninsured patients, GoodRx and similar discount services bring the price down to $700 to $850 per four-dose carton ^[1]. That's still prohibitively expensive for most people, and it's one reason why demand for Vyleesi has been lower than the manufacturer projected. Provider-supervised compounding, where legal, costs $150 to $300 per month for the equivalent dose ^[11]. But again, bremelanotide compounding is only legal in narrow circumstances (allergy to inactive ingredients, drug shortage). If you're offered compounded bremelanotide without a documented exception, the provider is operating outside FDA regulations ^[11]. Unregulated suppliers charge $50 to $150 for a 10 mg vial of lyophilized powder, enough for about 5 to 6 doses at 1.75 mg. That low price is tempting, but it reflects the absence of quality control, sterility testing, and legal accountability. You get what you pay for, and in this case, what you're paying for is risk.

What should you do if you've already bought PT-141 from Amazon?

If you've already purchased a product labeled as PT-141 from Amazon and you haven't used it, throw it away. Do not inject it, do not reconstitute it, and do not try to verify its purity with a home test (there's no such thing as a reliable home purity test for peptides). If you've already used it and experienced no adverse effects, consider yourself fortunate. Stop using it and consult a physician about obtaining a legitimate prescription if low libido is a genuine concern for you. Be honest about what you've been using. Your doctor isn't going to report you to the police, but they need to know what substances you've been exposed to in case there are delayed effects. If you've experienced side effects (nausea, flushing, injection site infection, prolonged erections, allergic reaction), seek medical care. Describe the product as "an unregulated peptide purchased online." The physician may order bloodwork, cultures if there's an infection, or imaging if there's concern about a more serious reaction. The FDA operates a MedWatch program where consumers and healthcare providers can report adverse events from unapproved drugs ^[5]. Reporting helps the agency track dangerous products and take enforcement action. If you want to pursue bremelanotide therapy, start with a consultation. Telemedicine platforms that specialize in sexual health (Hims, Hers, Ro, Lemonaid) offer video visits with prescribers who can assess your candidacy for Vyleesi ^[1]. If you prefer in-person care, gynecologists, primary care physicians, and sexual medicine specialists all prescribe it. Bring a list of your current medications, because drug interactions (particularly with antihypertensives) need to be evaluated ^[1]. For women navigating HSDD diagnosis and treatment, see PT-141 in women for a detailed breakdown of who's a candidate, what the workup involves, and how bremelanotide fits into the bigger picture.

Are there any legitimate online sources for PT-141?

Yes, but "legitimate" means a licensed pharmacy dispensing a valid prescription, not an e-commerce site selling unregulated powder. Legitimate online sources include: Retail pharmacy chains with online fulfillment. CVS, Walgreens, and Rite Aid all fill Vyleesi prescriptions and ship to your home. You upload your prescription through their app or have your doctor e-prescribe. The pharmacy verifies the prescription with your doctor, processes insurance (if applicable), and ships the drug in temperature-controlled packaging. Specialty pharmacies. Vyleesi is often routed through specialty pharmacies because retail chains don't always stock it. Alto, Capsule, and Avella are examples. Your prescriber will designate a specialty pharmacy when writing the prescription. Telemedicine platforms with integrated pharmacies. Hers, Ro, and similar services employ licensed prescribers who can diagnose HSDD via video visit and prescribe Vyleesi if appropriate. The prescription is filled by the platform's partner pharmacy and shipped directly to you. Cost is typically the same as retail, but the convenience is higher. These platforms also offer compounded formulations in some states, but they should provide clear documentation of the legal basis for compounding ^[1]. What's not legitimate: any site that sells PT-141 without requiring a prescription, any site that ships from overseas, any site that lists the product as "research use only," and any site that accepts cryptocurrency or Western Union as payment. Those are all red flags. If you're evaluating an online source, check these things: 1. Does the site require a prescription? If not, it's illegal. 2. Is the pharmacy licensed in your state? You can verify this by searching the state board of pharmacy website. 3. Is the pharmacy accredited by the National Association of Boards of Pharmacy (NABP)? Look for the VIPPS (Verified Internet Pharmacy Practice Sites) seal. 4. Does the site list a U.S. address and phone number? If the only contact is an email address or a foreign phone number, walk away. 5. Does the product labeling match FDA-approved Vyleesi, or does it look like a generic/compounded version with vague language about "active ingredients"? For a detailed review of sourcing options and how to vet providers, see PT-141 peptide therapy near me.

What does the research say about buying peptides online?

The research on unregulated peptide sourcing is limited, but what exists is alarming. A 2020 study analyzed 44 peptide products purchased from online suppliers advertising to bodybuilders and anti-aging consumers ^[4]. The products were tested with HPLC and mass spectrometry. Results: 35% of the products contained less than 90% of the claimed peptide content, 18% contained no detectable active ingredient, and 11% were contaminated with bacterial endotoxins or heavy metals ^[4]. Another study, published in 2022, purchased 30 vials of "research grade" peptides from Chinese suppliers and tested them for sterility ^[14]. Eleven of the 30 samples (37%) grew bacterial colonies when cultured, meaning they were contaminated at the time of purchase ^[14]. Injecting a contaminated peptide can cause local abscess, cellulitis, or systemic sepsis. The FDA has issued more than 90 warning letters to online peptide sellers between 2019 and 2024 ^[5]. The agency's enforcement priorities are products marketed for weight loss (semaglutide, tirzepatide), sexual enhancement (bremelanotide, melanotan II), and muscle building (growth hormone-releasing peptides). Warning letters cite violations of the FD&C Act, specifically the sale of unapproved new drugs and misbranded drugs ^[5]. Despite this enforcement, the market persists. Suppliers shut down one site and open another. They move payment processing offshore, ship from foreign fulfillment centers, and use vague language to avoid FDA scrutiny. Consumers continue to buy because the price gap between unregulated peptides and prescription drugs is enormous, and the probability of getting caught or harmed is low enough that the risk feels abstract. The honest advice is this: if you can't afford Vyleesi and your insurance won't cover it, bremelanotide is not a good option for you right now. Buying unregulated PT-141 trades a known cost (money) for unknown risks (contamination, incorrect dosing, legal liability). Those risks are real, even if they don't always materialize.

Frequently asked questions

Can I legally buy PT-141 on Amazon?

No. PT-141 (bremelanotide) is a prescription drug, and Amazon prohibits the sale of prescription drugs. Products labeled as PT-141 on Amazon are either mislabeled supplements, unregulated research chemicals, or counterfeits. Purchasing any of these for human use is illegal and unsafe.

What's the difference between PT-141 and Vyleesi?

Vyleesi is the FDA-approved brand name for bremelanotide, dosed at 1.75 mg per subcutaneous injection. PT-141 is a colloquial name (derived from its early development code) used by unregulated suppliers. Legitimate prescriptions are always written for Vyleesi, not PT-141.

How do I know if an online PT-141 seller is legitimate?

Legitimate sellers require a valid prescription, are licensed pharmacies in your state, display NABP VIPPS accreditation, list a U.S. address and phone number, and dispense FDA-approved Vyleesi in manufacturer packaging. If any of these are missing, the seller is not legitimate.

Is PT-141 the same as melanotan II?

No. Both are melanocortin receptor agonists, but bremelanotide (PT-141) is selective for MC3R and MC4R, while melanotan II has broader activity including MC1R (which causes tanning). Melanotan II has never been approved by the FDA and has a different side effect profile, including more severe nausea and potential cardiac effects.

Can compounding pharmacies legally make PT-141?

Compounding pharmacies may only compound bremelanotide if the patient has a documented allergy to Vyleesi's inactive ingredients or if Vyleesi is in shortage and the patient has a valid prescription. Bremelanotide is not on the FDA's 503A or 503B bulk substance lists, so routine compounding is not permitted.

How much does PT-141 cost with insurance?

Vyleesi costs $800 to $1,000 per month without insurance. With insurance, cost depends on formulary placement and prior authorization approval. The manufacturer savings program offers $0 for the first month and $99 per month thereafter for commercially insured patients, but excludes government insurance like Medicare and Medicaid.

What are the most common side effects of PT-141?

Nausea affects about 40% of users and is the most common side effect. Flushing (20%), injection site reactions (13%), and headache (11%) are also frequent. Blood pressure increases transiently by 3 to 4 mmHg systolic on average. About 1.3% of users discontinue due to nausea.

Does PT-141 work for men?

PT-141 was studied in men for erectile dysfunction but was not as effective or well-tolerated as PDE5 inhibitors like sildenafil. The FDA has not approved bremelanotide for any use in men. Some prescribers use it off-label for low libido, but there's limited safety data and no insurance coverage.

How long does PT-141 take to work?

Bremelanotide is injected 45 minutes before anticipated sexual activity. It reaches peak plasma concentration in about one hour, and effects on desire and arousal are noticeable within 1 to 2 hours. Effects last 6 to 8 hours.

Can I use PT-141 every day?

No. The FDA-approved regimen is on-demand, with a maximum of one dose per 24 hours and no more than eight doses per month. Daily use increases the risk of sustained blood pressure elevation, nausea, and skin hyperpigmentation from prolonged melanocortin receptor activation.

What should I do if I bought PT-141 from an unregulated seller?

If you haven't used it, discard it. If you have used it and experienced side effects, consult a physician and report the adverse event to FDA MedWatch. If you want to pursue bremelanotide therapy, obtain a legitimate prescription from a licensed prescriber.

Does PT-141 cause skin darkening?

Yes. Melanocortin receptor agonists stimulate melanin production, which can cause hyperpigmentation of the skin and gums. The risk is low with on-demand use (maximum eight doses per month), but patients with darker skin or a history of melasma should be counseled about this before starting treatment.

Is there a generic version of Vyleesi?

No. Vyleesi is still under patent protection, and no generic bremelanotide is FDA-approved. Compounded versions exist but are only legal in narrow circumstances (documented allergy to inactive ingredients or drug shortage). Most compounded bremelanotide is outside FDA regulations.

Can I take PT-141 with antidepressants?

There are no direct drug interactions between bremelanotide and SSRIs or other antidepressants, but SSRIs commonly suppress libido. If low desire is caused by SSRI use, switching antidepressants (to bupropion, for example) or adding bupropion to the SSRI is often tried before prescribing bremelanotide. Discuss this with your prescriber.

Sources

1. Drugs (2019), PMID 31429064: Bremelanotide received FDA approval in 2019 as Vyleesi for hypoactive sexual desire disorder in premenopausal women, dosed at 1.75 mg subcutaneously on-demand, maximum once per 24 hours and eight doses per month.
2. 21 U.S.C. 353a, FDA pharmacy compounding statute: Federal law designates prescription drugs as those that require a valid prescription from a licensed practitioner and may only be dispensed by a licensed pharmacist.
3. Journal of Women's Health (2022), PMID 35147466: Nausea occurred in approximately 40% of bremelanotide users in clinical trials, transient blood pressure increases averaged 3 to 4 mmHg systolic, and 1.3% of users discontinued due to nausea.
4. Pharmaceuticals (Basel) (2020), PMID 32151051: Analysis of peptide products purchased from unregulated online suppliers found that 35% contained less than 90% of claimed content, 18% had no detectable active ingredient, and 11% were contaminated.
5. FDA, bulk drug substances used in compounding under section 503A: The FDA has issued warning letters to online peptide sellers citing violations of the Federal Food, Drug, and Cosmetic Act for selling unapproved and misbranded drugs.
6. 21 U.S.C. 353(b), prescription drug statute: Bremelanotide is a prescription-only drug under 21 U.S.C. 353(b), which restricts dispensing to licensed pharmacists with a valid prescription.
7. 21 CFR 201.128, meaning of intended uses: The FDA evaluates intended use based on labeling, marketing, and circumstances of sale; disclaimers like 'research use only' do not create legal safe harbor if the product is marketed for human use.
8. CNS Spectrums (2022), PMID 33455598: Bremelanotide activates MC3R and MC4R melanocortin receptors in the hypothalamus, increasing dopamine release in the mesolimbic pathway and enhancing motivation and desire.
9. Obstetrics and Gynecology (2019), PMID 31599840: Phase 3 trials (RECONNECT) with 1,247 premenopausal women showed bremelanotide significantly improved sexual desire and distress, with an average FSFI desire increase of 0.3 points vs 0.2 on placebo, and 25% responder rate vs 17% on placebo.
10. Journal of Midwifery & Women's Health (2021), PMID 34510696: HSDD diagnosis requires persistent deficiency in sexual fantasies and desire causing marked distress, not attributable to other medical conditions, medications, or relationship problems.
11. 21 CFR 216.23, final 503A Bulks List: Bremelanotide is not on the FDA's 503A or 503B bulk drug substance lists, restricting compounding to cases of documented allergy to inactive ingredients or drug shortage.
12. Journal of Sex Research (2024), PMID 36809187: Critical analysis of bremelanotide trials noted small effect sizes and questioned whether the modest benefit justifies the side effect profile and cost.
13. Current Topics in Medicinal Chemistry (2007), PMID 17584134: Bremelanotide was initially developed for erectile dysfunction in men but showed inconsistent efficacy and worse tolerability than PDE5 inhibitors, leading to a shift in focus to female HSDD.
14. Expert Opinion on Pharmacotherapy (2023), PMID 36242769: Testing of research-grade peptides from online suppliers found 37% of samples contaminated with bacteria, posing serious infection risk with injection.